
GSK teams up with Strathclyde and University of Nottingham
pharmafile | July 16, 2019 | News story | Manufacturing and Production | GSK, GlaxoSmithKline, UK, britain, pharma, universities
GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at promoting new medical research.
The £12.9 million project has received £5.5 million in funding from the Engineering and Physical Sciences Research Council (ESPRC).
The partnership will see the three organisations team up to use machine learning and AI to identify new medicines and make the production of medicines more environmentally friendly.
The project is also intended to train a new cohort of postgraduate students and postdoctoral researchers.
Tony Wood, Senior Vice President, Medicinal Science & Technology at GSK said: “We are delighted with the EPSRC award which recognises the important work being done in collaboration with Nottingham and Strathclyde Universities.
“Together we are focused on the application of Artificial Intelligence/Machine Learning in synthetic chemistry, a discipline that is central to drug design and development of new medicines. The additional support will enable continued research hopefully delivering efficiency gains that bring meaningful benefit to the discovery of new medicines.”
Louis Goss
Related Content

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis
GSK’s Exdensur (depemokimab), a twice-yearly biological medicine, has received approval from the UK Medicines and …

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

Addenbrooke’s hospital offers first self-service digital eye test
Addenbrooke’s Hospital, Cambridge, has become the first in the UK to deploy a digital self-testing …





